These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7881465)

  • 1. Apoptosis: therapeutic significance in the treatment of androgen-dependent and androgen-independent prostate cancer.
    Kyprianou N
    World J Urol; 1994; 12(6):299-303. PubMed ID: 7881465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmed cell death as a new target for prostatic cancer therapy.
    Kyprianou N; Martikainen P; Davis L; English HF; Isaacs JT
    Cancer Surv; 1991; 11():265-77. PubMed ID: 1841755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined antitumor effect of suramin plus irradiation in human prostate cancer cells: the role of apoptosis.
    Sklar GN; Eddy HA; Jacobs SC; Kyprianou N
    J Urol; 1993 Nov; 150(5 Pt 1):1526-32. PubMed ID: 8411447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biology of hormone refractory prostate cancer. Why does it develop?
    Isaacs JT
    Urol Clin North Am; 1999 May; 26(2):263-73. PubMed ID: 10361549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target to apoptosis: a hopeful weapon for prostate cancer.
    Tang DG; Porter AT
    Prostate; 1997 Sep; 32(4):284-93. PubMed ID: 9288188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options in androgen-independent prostate cancer.
    Lara PN; Meyers FJ
    Cancer Invest; 1999; 17(2):137-44. PubMed ID: 10071598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-induced apoptosis: predictive and therapeutic significance in radiotherapy of prostate cancer (review).
    Szostak MJ; Kyprianou N
    Oncol Rep; 2000; 7(4):699-706. PubMed ID: 10854529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.
    Thalmann GN; Sikes RA; Chang SM; Johnston DA; von Eschenbach AC; Chung LW
    J Natl Cancer Inst; 1996 Jun; 88(12):794-801. PubMed ID: 8637045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction.
    Cuellar DC; Rhee J; Kyprianou N
    Anticancer Res; 2002; 22(3):1673-9. PubMed ID: 12168853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer.
    Denmeade SR; Lin XS; Isaacs JT
    Prostate; 1996 Apr; 28(4):251-65. PubMed ID: 8602401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis and clonogenic cell death in PC3 human prostate cancer cells after treatment with gamma radiation and suramin.
    Palayoor ST; Bump EA; Teicher BA; Coleman CN
    Radiat Res; 1997 Aug; 148(2):105-14. PubMed ID: 9254728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of apoptosis in androgen-independent human prostate cancer cells undergoing thymineless death.
    Kyprianou N; Bains AK; Jacobs SC
    Prostate; 1994 Aug; 25(2):66-75. PubMed ID: 8036180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative and cytotoxic effects of geldanamycin, cytochalasin E, suramin and thiacetazone in human prostate xenograft tumor histocultures.
    Gan Y; Au JL; Lu J; Wientjes MG
    Pharm Res; 1998 Nov; 15(11):1760-6. PubMed ID: 9834000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen regulation of programmed death of normal and malignant prostatic cells.
    Isaacs JT; Lundmo PI; Berges R; Martikainen P; Kyprianou N; English HF
    J Androl; 1992; 13(6):457-64. PubMed ID: 1293127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.
    Engedal N; Korkmaz CG; Saatcioglu F
    Oncogene; 2002 Feb; 21(7):1017-27. PubMed ID: 11850819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation.
    Kyprianou N; English HF; Isaacs JT
    Cancer Res; 1990 Jun; 50(12):3748-53. PubMed ID: 2340521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen blocks apoptosis of hormone-dependent prostate cancer cells.
    Kimura K; Markowski M; Bowen C; Gelmann EP
    Cancer Res; 2001 Jul; 61(14):5611-8. PubMed ID: 11454715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism and role of growth arrest in programmed (apoptotic) death of prostatic cancer cells induced by thapsigargin.
    Lin XS; Denmeade SR; Cisek L; Isaacs JT
    Prostate; 1997 Nov; 33(3):201-7. PubMed ID: 9365549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner.
    Feng FY; Zhang Y; Kothari V; Evans JR; Jackson WC; Chen W; Johnson SB; Luczak C; Wang S; Hamstra DA
    Neoplasia; 2016 Apr; 18(4):213-22. PubMed ID: 27108384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer.
    Hall SJ; Mutchnik SE; Yang G; Timme TL; Nasu Y; Bangma CH; Woo SL; Shaker M; Thompson TC
    Cancer Gene Ther; 1999; 6(1):54-63. PubMed ID: 10078964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.